5Van-Rossum T G, VultO A G, Hop W C, et al. Gly-cyrrhiZin-induced reduction of ALT in european patients with chronic hepatitis C[J]. AmJGastroenterol, 2001, 96(8): 2432.
6Van-Rossum T G, De-Jong F H, Hop W C, et al. Pseu-doaldostero-nism′ induced by intravenous glycyrrhizin treatment of chronic hepatitis C patients[J]. J Gastroen-terol Hepatol, 2001, 16(7): 789.
7Morazzoni P, Magistretti MJ, Giachetti C,et al. Comparatiue bioavailability of silipide,anew fiavanolignan complex,inrats [J].EarJ Drug Metab pharmacokinet, 1992,17 (1):39～44
8Schandalik R, Gatti G, Perucoa E, et al,Pharmactokinetics of silybin following administration of silipide and silymain in cholecy stectomy patients [J].Armleim-Forsch, 1992,42(7): 964～968
